Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 319 followers
Latest posts
Last updated about 15 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Rizmoic, naldemedine tosilate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: EMA/PE/0000226303
about 15 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Rizmoic, naldemedine tosilate, decision type...
Veterinary medicines European public assessment report (EPAR): Epizootic haemorrhagic disease vaccine (recombinant protein) Laboratorios Syva S.A., Epizootic haemorrhagic disease vaccine (recombinant protein), Status: Authorised
about 15 hours ago
Veterinary medicines European public assessment report (EPAR): Epizootic haemorrhagic disease vaccine (recombinant...
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 3, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation...
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 8, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation...
Fees payable to the European Medicines Agency: Guidance for all applicants
about 16 hours ago
Fees payable to the European Medicines Agency: Guidance for all applicants
Human medicines European public assessment report (EPAR): Sycrest, asenapine, Date of authorisation: 01/09/2010, Revision: 22, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Sycrest, asenapine, Date of authorisation...
Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 23, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation...
Human medicines European public assessment report (EPAR): DaTSCAN, ioflupane (123l), Date of authorisation: 27/07/2000, Revision: 26, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): DaTSCAN, ioflupane (123l), Date of...
Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 5, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of...